Reduced levels of proteasome products in a mouse striatal cell model of huntington's disease

Detalhes bibliográficos
Autor(a) principal: Dasgupta, Sayani
Data de Publicação: 2015
Outros Autores: Fishman, Michael A., Mahallati, Hana, Castro, Leandro M. [UNESP], Tashima, Alexandre K., Ferro, Emer S., Fricker, Lloyd D.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1371/journal.pone.0145333
http://hdl.handle.net/11449/168352
Resumo: Huntington's disease is the result of a long polyglutamine tract in the gene encoding huntingtin protein, which in turn causes a large number of cellular changes and ultimately results in neurodegeneration of striatal neurons. Although many theories have been proposed, the precise mechanism by which the polyglutamine expansion causes cellular changes is not certain. Some evidence supports the hypothesis that the long polyglutamine tract inhibits the proteasome, a multiprotein complex involved in protein degradation. However, other studies report normal proteasome function in cells expressing long polyglutamine tracts. The controversy may be due to the methods used to examine proteasome activity in each of the previous studies. In the present study, we measured proteasome function by examining levels of endogenous peptides that are products of proteasome cleavage. Peptide levels were compared among mouse striatal cell lines expressing either 7 glutamines (STHdhQ7/Q7) or 111 glutamines in the huntingtin protein, either heterozygous (STHdhQ7/Q111) or homozygous (STHdhQ111/Q111). Both of the cell lines expressing huntingtin with 111 glutamines showed a large reduction in nearly all of the peptides detected in the cells, relative to levels of these peptides in cells homozygous for 7 glutamines. Treatment of STHdhQ7/Q7 cells with proteasome inhibitors epoxomicin or bortezomib also caused a large reduction in most of these peptides, suggesting that they are products of proteasome-mediated cleavage of cellular proteins. Taken together, these results support the hypothesis that proteasome function is impaired by the expression of huntingtin protein containing long polyglutamine tracts.
id UNSP_4e9ab845c81839371f8f9e2febee5ba3
oai_identifier_str oai:repositorio.unesp.br:11449/168352
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Reduced levels of proteasome products in a mouse striatal cell model of huntington's diseaseHuntington's disease is the result of a long polyglutamine tract in the gene encoding huntingtin protein, which in turn causes a large number of cellular changes and ultimately results in neurodegeneration of striatal neurons. Although many theories have been proposed, the precise mechanism by which the polyglutamine expansion causes cellular changes is not certain. Some evidence supports the hypothesis that the long polyglutamine tract inhibits the proteasome, a multiprotein complex involved in protein degradation. However, other studies report normal proteasome function in cells expressing long polyglutamine tracts. The controversy may be due to the methods used to examine proteasome activity in each of the previous studies. In the present study, we measured proteasome function by examining levels of endogenous peptides that are products of proteasome cleavage. Peptide levels were compared among mouse striatal cell lines expressing either 7 glutamines (STHdhQ7/Q7) or 111 glutamines in the huntingtin protein, either heterozygous (STHdhQ7/Q111) or homozygous (STHdhQ111/Q111). Both of the cell lines expressing huntingtin with 111 glutamines showed a large reduction in nearly all of the peptides detected in the cells, relative to levels of these peptides in cells homozygous for 7 glutamines. Treatment of STHdhQ7/Q7 cells with proteasome inhibitors epoxomicin or bortezomib also caused a large reduction in most of these peptides, suggesting that they are products of proteasome-mediated cleavage of cellular proteins. Taken together, these results support the hypothesis that proteasome function is impaired by the expression of huntingtin protein containing long polyglutamine tracts.Department of Molecular Pharmacology Albert Einstein College of Medicine, 1300 Morris Park AveSão Paulo State University (UNESP) Experimental Campus on the São Paulo CoastDepartment of Biochemistry Escola Paulista de Medicina Federal University of Sao PauloDepartment of Pharmacology Biomedical Science Institute University of São PauloDepartment of Neuroscience Albert Einstein College of Medicine, 1300 Morris Park AveSão Paulo State University (UNESP) Experimental Campus on the São Paulo CoastAlbert Einstein College of MedicineUniversidade Estadual Paulista (Unesp)Universidade de São Paulo (USP)Dasgupta, SayaniFishman, Michael A.Mahallati, HanaCastro, Leandro M. [UNESP]Tashima, Alexandre K.Ferro, Emer S.Fricker, Lloyd D.2018-12-11T16:40:55Z2018-12-11T16:40:55Z2015-12-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://dx.doi.org/10.1371/journal.pone.0145333PLoS ONE, v. 10, n. 12, 2015.1932-6203http://hdl.handle.net/11449/16835210.1371/journal.pone.01453332-s2.0-849569427362-s2.0-84956942736.pdfScopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengPLoS ONE1,164info:eu-repo/semantics/openAccess2023-10-15T06:10:11Zoai:repositorio.unesp.br:11449/168352Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462023-10-15T06:10:11Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Reduced levels of proteasome products in a mouse striatal cell model of huntington's disease
title Reduced levels of proteasome products in a mouse striatal cell model of huntington's disease
spellingShingle Reduced levels of proteasome products in a mouse striatal cell model of huntington's disease
Dasgupta, Sayani
title_short Reduced levels of proteasome products in a mouse striatal cell model of huntington's disease
title_full Reduced levels of proteasome products in a mouse striatal cell model of huntington's disease
title_fullStr Reduced levels of proteasome products in a mouse striatal cell model of huntington's disease
title_full_unstemmed Reduced levels of proteasome products in a mouse striatal cell model of huntington's disease
title_sort Reduced levels of proteasome products in a mouse striatal cell model of huntington's disease
author Dasgupta, Sayani
author_facet Dasgupta, Sayani
Fishman, Michael A.
Mahallati, Hana
Castro, Leandro M. [UNESP]
Tashima, Alexandre K.
Ferro, Emer S.
Fricker, Lloyd D.
author_role author
author2 Fishman, Michael A.
Mahallati, Hana
Castro, Leandro M. [UNESP]
Tashima, Alexandre K.
Ferro, Emer S.
Fricker, Lloyd D.
author2_role author
author
author
author
author
author
dc.contributor.none.fl_str_mv Albert Einstein College of Medicine
Universidade Estadual Paulista (Unesp)
Universidade de São Paulo (USP)
dc.contributor.author.fl_str_mv Dasgupta, Sayani
Fishman, Michael A.
Mahallati, Hana
Castro, Leandro M. [UNESP]
Tashima, Alexandre K.
Ferro, Emer S.
Fricker, Lloyd D.
description Huntington's disease is the result of a long polyglutamine tract in the gene encoding huntingtin protein, which in turn causes a large number of cellular changes and ultimately results in neurodegeneration of striatal neurons. Although many theories have been proposed, the precise mechanism by which the polyglutamine expansion causes cellular changes is not certain. Some evidence supports the hypothesis that the long polyglutamine tract inhibits the proteasome, a multiprotein complex involved in protein degradation. However, other studies report normal proteasome function in cells expressing long polyglutamine tracts. The controversy may be due to the methods used to examine proteasome activity in each of the previous studies. In the present study, we measured proteasome function by examining levels of endogenous peptides that are products of proteasome cleavage. Peptide levels were compared among mouse striatal cell lines expressing either 7 glutamines (STHdhQ7/Q7) or 111 glutamines in the huntingtin protein, either heterozygous (STHdhQ7/Q111) or homozygous (STHdhQ111/Q111). Both of the cell lines expressing huntingtin with 111 glutamines showed a large reduction in nearly all of the peptides detected in the cells, relative to levels of these peptides in cells homozygous for 7 glutamines. Treatment of STHdhQ7/Q7 cells with proteasome inhibitors epoxomicin or bortezomib also caused a large reduction in most of these peptides, suggesting that they are products of proteasome-mediated cleavage of cellular proteins. Taken together, these results support the hypothesis that proteasome function is impaired by the expression of huntingtin protein containing long polyglutamine tracts.
publishDate 2015
dc.date.none.fl_str_mv 2015-12-01
2018-12-11T16:40:55Z
2018-12-11T16:40:55Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1371/journal.pone.0145333
PLoS ONE, v. 10, n. 12, 2015.
1932-6203
http://hdl.handle.net/11449/168352
10.1371/journal.pone.0145333
2-s2.0-84956942736
2-s2.0-84956942736.pdf
url http://dx.doi.org/10.1371/journal.pone.0145333
http://hdl.handle.net/11449/168352
identifier_str_mv PLoS ONE, v. 10, n. 12, 2015.
1932-6203
10.1371/journal.pone.0145333
2-s2.0-84956942736
2-s2.0-84956942736.pdf
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv PLoS ONE
1,164
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv Scopus
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1797789406944296960